Categories
Entrevues

Interview with Christophe Baron, Founder of Louis App: “NFTs to promote disease prevention and longevity”

Questions asked by Alexandre Demailly

We thank Mr Christophe Baron for his time and answers and wish Louis App a long life! To discover the app: https://www.louisapp.io/

1] Could you introduce your company and the project it is developing?

We started from the fact that life expectancy is decreasing, and that healthy life expectancy is stagnating because of our lifestyles: sedentary lifestyle and bad diet. These habits are not easy to change, and we have tried to find a way to make the user understand that his lifestyle has a direct impact on his life expectancy. (See studies cited at the bottom of the article).

2] Why do you think it is necessary to focus on prevention? Can you tell us more about the “life minutes” concept developed by your company? How was the intellectual property referring to it created?

The adage “il vaut mieux prévenir que guérir” (prevention is better than cure) is not only common sense but also science. Prevention really helps to prevent diseases from appearing. Sometimes people change their lifestyle, but it is too late. Someone who has smoked 20 cigarettes a day for 25 years will take a long time to get their lungs back in good condition and the disease may still set in.

Louis App is a preventive health application that measures your progress through a counter of life minutes gained by eating better and moving more. It is unique and we have filed a patent with the INPI. (Notes from Resolving Pharma:  French National Institute of Intellectual Property)

Today, you can record your physical activity and your meals and measure the impact with a 20-year projection. We are in the process of setting up AI to take a photo of the meal and then the application will recognize the content and the food family. In the same way, in a second version, we are going to offer automatic recovery of physical activity from the smartphone and other devices to reduce data entry to a minimum.

3] How does your app differ from a project like Step’N which encourages users to engage in physical activity but focuses on the financial aspects (including the need for an initial investment)?

StepN is a great app that is aimed at a cryptocurrency savvy audience and requires the purchase of a pair of trainers (Notes from Resolving Pharma: Indeed, the purchase of an NFT – representing a trainer – is required to use the app)

In contrast, the Louis app is aimed at a lay audience in which users will see their progress through levels but also through money: Health and Earn. Furthermore, we consider diet and smoking, which is not the case in StepN.

4] What is the purpose of the NFTs distributed to the users of the application?

This is still being finalized, but it is likely that users will be rewarded with discounts from health, sport and nutrition partners. We are in contact with dieticians who could coach our users with a discounted price. In addition, other highly motivating and understandable rewards are also planned.

5] You will also integrate a token into your project. What will it be used for? What mechanisms will govern its economy?

NFT and tokens will be linked and at this stage we prefer not to say too much. Again, this terminology will not be used, and we will speak a language that everyone can understand.

6] What is the infrastructure blockchain used by your project and what were the arguments that motivated your choice?

The technical choices have not yet been made, we are studying different solutions including Polygon (Notes from Resolving Pharma: Polygon is a second layer solution of the Ethereum Blockchain, which allows transactions to take place on a network with lower fees and higher speed than on the Ethereum Blockchain while maintaining interoperability with it)

7] Do you plan to carry out an ICO/STO/IDO or to use the cryptocurrency universe to find funding (I’m thinking of the grant programmes set up by certain blockchains)?

Yes, an ICO is planned: it will allow us to reward our users, to set up a DAO in order to vote for projects related to R&D (against diabetes for example), it will also allow us to recruit to improve the application and launch new modules; We have just launched a very easy to use diabetes prevention module and plan to launch a heart prevention module, cancer prevention, compliance…. Our road map is very well structured. We know that at least 40% of cancers are caused by our lifestyles and could therefore be avoided!

Very soon we will launch an Ulule campaign to communicate. Please follow us and participate…. There will be a very nice surprise in return.

8] Currently, only 8% of French people hold cryptocurrencies. What do you plan to do to demystify this world for the patients who will use your application?

We will not talk about crypto in the application but about progress linked to prevention through life minutes gained, milestones reached and monetary rewards.

9] What are the pillars on which your company’s business model is based?

The app is free today, but we will move to a freemium model with monthly or annual subscriptions.

10] Projects combining Blockchain and Health are still relatively rare in France. How are Web3 themes perceived in the French health start-up ecosystem?

Some people talk about medical training in the metaverse, health coaching…. I think it is still too early to have a clear vision.

11] What advice would you give to a young entrepreneur wishing to launch a project at the crossroads of Web3 and health?

3 very simple and essential things:

  • Set up a scientific council
  • Don’t hesitate to get coaching
  • Read, be constantly on the lookout

To go further:

These articles should interest you

Vitalik_Buterin_Scientist_Landscape

Introduction to DeSci

How Science of the Future is being born before our eyes « [DeSci] transformed my research impact from a low-impact virology article every other year to saving the lives and…
Illustration In Silico

Towards virtual clinical trials?

Clinical trials are among the most critical and expensive steps in drug development. They are highly regulated by the various international health agencies, and for good reason: the molecule or…

To subscribe free of charge to the monthly Newsletter, click here.

Would you like to take part in the writing of Newsletter articles ? Would you like to take part in an entrepreneurial project on these topics ?

Contact us at hello@resolving-pharma.com ! Join our group LinkedIn !

By Alexandre Demailly

Pharmacist graduated from Lille University, France, Alexandre pursued his studies in Medical Economics at the Paris-Dauphine University and developed his knowledge of Artificial Intelligence in Health at the University of Paris.
Passionate about health innovation and entrepreneurship, Alexandre is currently involved in two early stage biotechs in the neurodegenerative diseases field.